Stemedica

6350 Nancy Ridge Dr Ste 102
San Diego, CA 92121

Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to the development and commercialization of progenitor cell and protein therapeutics aimed at addressing underserved medical conditions. The company boasts a team of experienced scientists and management, utilizing proprietary technology to produce high-quality progenitor cell products in compliance with stringent standards.

Currently, Stemedica is advancing clinical trials in the United States for several critical medical conditions, including chronic ischemic stroke. The company has recently appointed Michael K. Steinhauser as CEO and Interim Chairman, further strengthening its leadership as it initiates Phase IIb/III clinical trials.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.